US Senate passes bill to boost participation in rare diseases trials
This article was originally published in SRA
Executive Summary
The US Senate has cleared a bill that, if signed into law, will allow patients with rare diseases to participate in clinical research studies without losing their eligibility for public assistance benefits1,2.